China
· Delayed Price · Currency is CNY Hangzhou Biotest Biotech Statistics
Total Valuation
SHA:688767 has a market cap or net worth of CNY 4.07 billion. The enterprise value is 2.44 billion.
| Market Cap | 4.07B |
| Enterprise Value | 2.44B |
Important Dates
The last earnings date was Saturday, April 26, 2025.
| Earnings Date | Apr 26, 2025 |
| Ex-Dividend Date | Jan 10, 2025 |
Share Statistics
SHA:688767 has 104.52 million shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 104.52M |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +3.16% |
| Owned by Insiders (%) | 27.93% |
| Owned by Institutions (%) | 5.24% |
| Float | 36.53M |
Valuation Ratios
The trailing PE ratio is 28.40.
| PE Ratio | 28.40 |
| Forward PE | n/a |
| PS Ratio | 7.93 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 1.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.76 |
| EV / Sales | 4.76 |
| EV / EBITDA | n/a |
| EV / EBIT | 14.22 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.74, with a Debt / Equity ratio of 0.00.
| Current Ratio | 16.74 |
| Quick Ratio | 15.60 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 5.98% and return on invested capital (ROIC) is 4.43%.
| Return on Equity (ROE) | 5.98% |
| Return on Assets (ROA) | 4.20% |
| Return on Invested Capital (ROIC) | 4.43% |
| Return on Capital Employed (ROCE) | 7.06% |
| Revenue Per Employee | 815,337 |
| Profits Per Employee | 231,772 |
| Employee Count | 629 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.25% in the last 52 weeks. The beta is 0.48, so SHA:688767's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +42.25% |
| 50-Day Moving Average | 37.49 |
| 200-Day Moving Average | 31.39 |
| Relative Strength Index (RSI) | 52.83 |
| Average Volume (20 Days) | 917,723 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688767 had revenue of CNY 512.85 million and earned 145.78 million in profits. Earnings per share was 1.37.
| Revenue | 512.85M |
| Gross Profit | 540.37M |
| Operating Income | 171.86M |
| Pretax Income | 168.27M |
| Net Income | 145.78M |
| EBITDA | n/a |
| EBIT | 171.86M |
| Earnings Per Share (EPS) | 1.37 |
Balance Sheet
The company has 1.63 billion in cash and 1.07 million in debt, giving a net cash position of 1.63 billion or 15.56 per share.
| Cash & Cash Equivalents | 1.63B |
| Total Debt | 1.07M |
| Net Cash | 1.63B |
| Net Cash Per Share | 15.56 |
| Equity (Book Value) | 2.42B |
| Book Value Per Share | 22.19 |
| Working Capital | 1.71B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 105.37%, with operating and profit margins of 33.51% and 28.43%.
| Gross Margin | 105.37% |
| Operating Margin | 33.51% |
| Pretax Margin | 32.81% |
| Profit Margin | 28.43% |
| EBITDA Margin | n/a |
| EBIT Margin | 33.51% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.57%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 2.57% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.71% |
| Shareholder Yield | 1.86% |
| Earnings Yield | 3.58% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |